Skip to main content

Advertisement

Log in

Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objectives

This study was designed to investigate the distribution of human leukocyte antigen (HLA) classes I and II in a group of Israeli Jewish patients with psoriatic arthritis (PsA) and identify HLA markers related to disease manifestation in PsA.

Patients and methods

Human leukocyte antigens class I and class II (both serologically and from oligotyping) were tested in a group of 50 consecutive patients with PsA, 32 with skin psoriasis (PSO), and 255 healthy persons. Data on age, gender, disease duration, and pattern of rheumatological manifestations—oligoarthritis, polyarthritis, spinal involvement, involvement of distal interphalangeal joints (DIPs), and enthesitis—were registered.

Results

Human leukocyte antigens A3, B13, and B38 alleles were found to be significantly prevalent in PsA compared with PSO patients and healthy controls. HLA-B27 was found in only two out of 50 patients with PsA. Patients with PSO and PsA had significantly increased incidence of HLA-DRB0101 and -DRB0301, while the frequency of HLA-DRB0403 was significantly higher among patients with PsA of Ashkenazi origin. We found a statistically significant association between DIP involvement and the presence of HLA-A26 and -B38, while HLA-DRB0301 was related to spinal involvement.

Conclusions

Psoriatic arthritis in Israeli patients seems to be associated with the presence of HLA-A3, -B13, -B38, -DRB0101, and -DRB0301. HLA-B27 was not a marker of PsA in this cohort of patients, including patients with psoriatic spondyloarthropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gladman D, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic arthritis—multivariate relative risk model. J Rheumatol 22:675–679

    CAS  PubMed  Google Scholar 

  2. Alibert JL (1918) Précis théorique sur les maladies de la peau. Ravier, Paris

  3. Gladman DD, Shuckett R, Russel ML, Thorne JC, Shachter RH (1987) Psoriatic arthritis—an analysis of 220 patients. Q J Med 62:127–141

    CAS  PubMed  Google Scholar 

  4. Espinoza LR (1985) Psoriatic arthritis: further epidemiologic and genetic consideration. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis. Grune and Stratton, Orlando, pp 9–32

  5. Gladmam DD (1985) The role of immunological factors in the pathogenesis and etiology of psoriatic arthritis. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis. Grune and Stratton, Orlando, pp 33–44

  6. Farber EM, Nall ML (1971) Genetics of psoriasis—twin study. In: Farber EM, Cox AJ (eds) Psoriasis. Proceeding of the International Symposium, Stanford University. Stanford University Press, Stanford, pp 7–13

  7. Moll JMH, Wright V (1973) Familial occurrence of psoriatic arthritis. Ann Rheum Dis 32:181–201

    CAS  PubMed  Google Scholar 

  8. Kammer GM, Soter NA, Gibson DJ et al (1979) Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9:75–97

    CAS  PubMed  Google Scholar 

  9. Gladman DD, Anhorn KAB, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13:586–592

    CAS  PubMed  Google Scholar 

  10. Roiterg-Tambur CS, Friedman AW, Safirman C, Sherman L, Battat S, Nelken D, Brautbar C (1995) Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46:104–110

    PubMed  Google Scholar 

  11. Schiff B, Mizrahi Y, Orgad S, Yaron M, Gazit E (1982) Association of HLA-Aw31 and HLA-DR1 in patients with adult rheumatoid arthritis. Ann Rheum Dis 4:403–404

    Google Scholar 

  12. Roudier J (2000) Association of MHC and Rheumatoid arthritis with HLA-DR4: the role of repertoire selection. Arthritis Res 2:217–220

    Article  CAS  PubMed  Google Scholar 

  13. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y (1978) Microdoplet testing for HLA-A, B, C and D antigens. Isr J Clin Pathol 69:103–120

    CAS  Google Scholar 

  14. Miller SA, Dykes DD, Polesky HF (1988) A sampling salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    PubMed  Google Scholar 

  15. Kimura A, Sasazuki T (1991) Eleventh International Histocompatibility Workshop reference protocol for the HLA-DNA typing technique. In: HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop Conference, vol 1. Oxford University Press, New York, pp 397–419, 1991

  16. Eleventh International Histocompatibility Workshop Conference (1991) HLA 1991, vol 1. Oxford University Press, New York

  17. Roux H, Mercier P, Maestracci D et al (1977) Psoriatic arthritis and HLA antigens. J Rheumatology 3 [Suppl 1]:64–65

    Google Scholar 

  18. O'Donnel, O'Loughlin S, Codd MB, Powell FC (1993) HLA typing in Irish psoriatics. Ir Med J 86:65–68

    PubMed  Google Scholar 

  19. Espinoza LR, Vasey FB, Wilkinson OR, Osterland CH (1978) Association between HLA-B38 and peripheral psoriatic arthritis. Arthritis Rheum 21:72–75

    CAS  PubMed  Google Scholar 

  20. Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, Nigra TP (1980) Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 66:670–675

    CAS  PubMed  Google Scholar 

  21. Braun J, Bollow M, Reminger G, Eggens U, Rudwaleit M, Distler A, Sieper J (1998) Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–67

    Article  CAS  PubMed  Google Scholar 

  22. Lambert JR, Wright S, Rajah SM, Moll MH (1976) Histocompatibility antigens in psoriatic arthritis. Ann Rheum Dis 35:526–530

    CAS  PubMed  Google Scholar 

  23. Eastmond CJ, Woodrow JC (1977) The HLA system and the arthropathies associated with psoriasis. Ann Rheum Dis 36:112–120

    CAS  PubMed  Google Scholar 

  24. Amstrong RD, Panayi GS, Welsh KI (1983) Histocompatibility antigens in psoriasis, psoriatic arthritis and ankylosing spondylitis. Ann Rheum Dis 42:142–146

    PubMed  Google Scholar 

  25. Marsal S, Armandans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38:332–337

    Google Scholar 

  26. Brautbar C, Porat S, Nerken D, Gabriel KR, Cohen T (1977) HLA B27 and ankylosing spondylitis in the Israeli population. J Rheumatol Suppl 3:24–32

    CAS  PubMed  Google Scholar 

  27. Schlosstein L, Terasaki PI, Bluestone R et al (1973) High association of an HLA antigen w27 with ankylosing spondylitis. N Engl J Med 288:704–706

    CAS  PubMed  Google Scholar 

  28. De Vries N, Ronningen KS, Tilanus MG, Bouwns-Rombouts A, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C (1993) HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41:26–30

    PubMed  Google Scholar 

  29. Gladman D, Farewell VT, Kopciuk KA, Cook RJ (1998) HLA markers and progression in psoriatic arthritis. J Rheumatol 25:730–733

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ori Elkayam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elkayam, O., Segal, R. & Caspi, D. Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis. Rheumatol Int 24, 93–97 (2004). https://doi.org/10.1007/s00296-003-0325-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-003-0325-0

Keywords

Navigation